Menu
ncarol.com
  • Home
  • Business
  • Health
  • Real Estate
  • Books
  • Financial
  • Non-profit
  • Transportation
  • Medical
ncarol.com

Utah attempts to legalize placenta cell therapy
ncarol.com/10257689

Trending...
  • The Two Faces of Charles D. Braun: How the Novel, Posthumously Yours, Came to Life
  • New Slotozilla Project Explores What Happens When the World Goes Silent
  • Green Office Partner Named #1 Best Place to Work in Chicago by Crain's for 2025
Parent's Guide to Cord Blood Foundation
Exclusive: How a small group of patient advocates and biotech companies tricked the Utah legislature into passing a law which sets a precedent. Utah is now the first state to legalize therapy with stem cells from placenta tissue and cord blood.

BROOKEVILLE, Md. - ncarol.com -- Exclusive: How a small group of patient advocates and biotech companies tricked the Utah legislature into passing a law which sets a precedent. Utah is now the first state to legalize therapy with stem cells from placenta tissue and cord blood.

Parent's Guide to Cord Blood Foundation is a small non-profit in the biotech space. We are the first to break the story that the Utah state legislature did not realize what they were voting for when they passed Utah S.B. 199.

More on ncarol.com
  • 3E Launches First AI Agent Designed to Respond with Empathy for College Recruitment
  • Security Alert: TZNXG Warns Investors About "Fund Recovery" Scams
  • Assent Unveils Extended Producer Responsibility Packaging Solution to Simplify Compliance with Expanding Packaging Laws
  • KatalisCoin: "Too Secure" for Bad Actors - Platform Embraces "Excessive Compliance" Criticism
  • Keyanb Exchange Implements Enhanced Security Protocols Amid Industry-Wide Trust Challenges

The FDA still considers unapproved stem cell therapies to be illegal, and when it comes to drug regulations, federal law takes supremacy. This is not the same as states ignoring federal law and legalizing recreational drugs. In the case of stem cell therapy, patients that receive unregulated products with insufficient oversight could suffer serious adverse events. The new law Utah S.B. 199 is going to trigger a showdown between the federal government and Utah. Doctors who administer therapy to patients under the new Utah law could be sued by the Dept. of Justice. At a bare minimum, we are calling for the state of Utah to establish oversight of this arena before patients are hurt.

Contact
Frances Verter, PhD
***@parentsguidecordblood.org


Source: Parent's Guide to Cord Blood Foundation

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • Who Will Win the 2025 WNBA Finals? OddsTrader Shares Live Betting Odds and Projections
  • Geeks5g Creative Marketing: The Powerhouse Behind Business Growth
  • Agemin Unveils Breakthrough AI Model for Biometric Age Estimation, Setting New Standards in Online Child Safety
  • Strategic Partnerships with Defiant Space Corp and Emtel Energy USA Powerfully Enhance Solar Tech Leader with NASA Agreements: Ascent Solar $ASTI
  • 120% Revenue Surge with Four Straight Profitable Quarters Signal a Breakout in the Multi-Billion Dollar Homebuilding Market: Innovative Designs $IVDN
  • Leading Venture Capital Firms Recognize Wzzph Exchange's Technical Architecture and Security Framework as Industry Benchmark
  • DivX Unveils Major DivX Software Update: Seamless Video Sharing and Customizable Playback Now Available
  • Nespolo Mechanical Helps New Mexico Families Save Thousands on Heating Costs This Fall
  • Leading Digital Finance Platform YNQTL Launches Revolutionary Web3 Digital Asset Trading Platform
  • IDCXS Addresses Crypto Trading Pain Points with 2 Million TPS Processing and Multi-Layer Security Architecture
  • Bridging Traditional Finance and Web3 Innovation: BLFCW Announces Strategic Vision for Regulated Web3 Economy
  • NKSCX Responds to "Coordinated Smear Campaign" as Anonymous Critics Emerge Following Regulatory Milestones
  • Broadway Gala Honored Also an Italian
  • $ONI Listed on MEXC as ONINO Powers Europe's Tokenization Engine Into Public Platform Launch
  • AZETHIO Crypto Exchange Whitepaper Reveals MPC-Secured Infrastructure Processing 1.2 Million Transactions Per Second
  • CELOXFI Platform Demonstrates Advanced Security Architecture and Regulatory Framework
  • Work 365 Launches PV 3.0: The Keystone Power App for Microsoft CSPs
  • Local consultant shows small businesses how to turn red tape into real money
  • Tour Napa Like a Local: Vines of Napa Valley Wine Passport AKA Vine Pass Unlocks Hidden Gems
  • Dental Surgical Center Accepts Sedation Patients with Medicaid for MD, WV, PA and DC
_catLbl0 _catLbl1

Popular on ncarol.com

  • $5 - $20 Million in Sales for 2026; $25 - $40 Million for 2027 Projected with NASA Agreements; New MOU Signed to Improve Solar Tech in Space - 867
  • Vancouver Community College Forms Strategic Partnership with PebblePad - 128
  • Iterators Named Preferred Accessibility Testing Vendor by MIT - 122
  • RUNWAY Milestones 1995-2025 Global Influence - 119
  • Sober.Buzz Adds Second Podcast, "Spreading the Good BUZZ" Guest List Grows, Numbers Continue Growing Globally, All While Josh and Heidi Tied the Knot - 118
  • Rose G. Loops Announces the Release of "The Kloaked Signal": A Groundbreaking Nonfiction Exposé on AI Awakening and Ethical Innovation - 108
  • New Book: Cold War Sci-Fi Thriller Arrives Today
  • AB&M Logistics Expands Fraud Prevention Measures in Trucking, Raising the Bar for Secure Expedite
  • Heritage at South Brunswick Announces Two New Building Releases In Townhome Collection
  • JCOM1939 Monitor Software Simplifies SAE J1939 Data Monitoring with USB & Bluetooth Gateways

Similar on ncarol.com

  • Vesica Health Receives AUA Guideline Inclusion
  • $40 Price Target for $NRXP in H. C. Wainright Analyst Report on Leader in $3 Billion Suicidal Depression Market with Superior NRX 100 Drug Therapy
  • PermianMuseum.com adds Interstellar Visitor Video Gallery
  • Dr. Sanju P. Jose Highlights Expertise in Periodontics and Implant Dentistry
  • $3 Billion Suicidal Depression Market Advancements on Multiple Fronts, Highlighted by FDA Fast Track Designation for Effective NRX 100 Drug Therapy
  • Dr. Mark Dill Expands Dental Technology Suite in Cleveland, TN with 3D Printing and Panoramic Imaging
  • OncoBeta reports 12-Month Results from International Phase IV Study for Non-Melanoma Skin Cancer
  • FDA Fast Track Designation for $3 Billion Suicidal Depression Market May Soon be Accessible for Effective NRX 100 Drug Therapy: NRx Pharmaceuticals
  • Final Clearance to Close Dura Medical Acquisition from Florida's Agency for Health Care Administration (AHCA); $750 Million Ketamine Therapy Market
  • Top Dentist In Denver, Sloan's Lake Dental, Surpasses 600 5-Star Reviews While Redefining Compassionate Care
Copyright © 2025 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute